Lazarex chairman Dana Dornsife says that there’s a “48 percent failure rate of clinical trials, and it's not because the drug didn't work.” Why do some medicines never make it to market? Watch now to find out.
Published:
Which clinical trial is the best choice for you? Watch now to hear Dr. Mike Thompson and patient advocate Jim Omel discuss factors to consider when weighing your options and share tips for patients trying to prioritize different trials.
Published:
Myeloma survivor Reina Weiner and Lazarex chairman Dana Dornsife discuss ways patients can learn about new clinical trial opportunities and share resources to help alleviate the financial burden.
Published:
Many patients wonder; how safe are clinical trials? How transparent is the data from clinical research? Tune in to hear Dr. Mike Thompson and Jim Omel discuss clinical trial care and how the efficacy of new cancer treatments is determined.
Published:
Eligibility criteria determines who can and cannot participate in a clinical trial. Do today’s studies reflect the actual patient population? Why is inclusion so narrow in some cases? Watch now to hear from Dr. Mike Thompson and Jim Omel.
Published:
More often than not, only a small fraction of patients enroll in a trial due to barriers posed by financial logistics, distrust and travel, to name a few. How do we remove obstacles, clearing the way for patients to have more access to clinical trials? Watch now to find out.
Published:
A panel of experts discuss how precision medicine may influence trial eligibility, cost of treatment, pace of drug development and more. Can biomarkers make the clinical trial process more efficient? Watch now to find out.
Published:
Are innovative treatments and testing offered closer to home? Expert Dr. Mike Thompson discusses local clinical trial options for cancer patients.
Published:
Can mind-body medicine strategies provide relief from treatment side effects? Watch now to hear noted expert Dr. Ishwaria Subbiah give recommendations for side effect management.
Published:
